Search company, investor...
Binx Health company logo

Binx Health

mybinxhealth.com

Founded Year

2005

Stage

Series E | Alive

Total Raised

$203.5M

Last Raised

$104M | 2 yrs ago

Mosaic Score
The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.

+20 points in the past 30 days

About Binx Health

Binx Health is an in vitro diagnostics Point-of-Care (POC) company that provides at-home STI testing. The platform also includes evidence-based testing, counseling, treatment, and follow up in order to increase screening and reduce infections.

Headquarters Location

245 First St

Cambridge, Massachusetts, 02142,

United States

646-847-8573

Missing: Binx Health's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

ESPs containing Binx Health

The ESP matrix leverages data and analyst insight to identify and rank leading companies in a given technology landscape.

EXECUTION STRENGTHMARKET STRENGTHLEADERHIGHFLIEROUTPERFORMERCHALLENGER
Healthcare / Healthcare Providers Tech

Companies in this market are developing technology to support rapid at-home diagnostic testing.

Binx Health named as Challenger among 8 other companies, including Color, Sherlock Biosciences, and Viome.

Missing: Binx Health's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Research containing Binx Health

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned Binx Health in 2 CB Insights research briefs, most recently on Apr 11, 2022.

Expert Collections containing Binx Health

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Binx Health is included in 7 Expert Collections, including Medical Devices.

M

Medical Devices

11,892 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

H

Health Monitoring & Diagnostics

3,443 items

Companies developing or offering products that aid in the assessment, screening, diagnosis, or monitoring of a person's state of health/wellness. Excludes companies focused solely on fitness/sports performance

O

Omics

1,267 items

Companies involved in the capture, sequencing, and/or analysis of genomic, transcriptomic, proteomic, and/or metabolomic data

D

Digital Health

13,355 items

Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)

D

Digital Health 150

150 items

The winners of the third annual CB Insights Digital Health 150.

H

Health IT

7,901 items

Binx Health Patents

Binx Health has filed 1 patent.

The 3 most popular patent topics include:

  • Molecular biology
  • Biotechnology
  • Molecular biology techniques
patents chart

Application Date

Grant Date

Title

Related Topics

Status

5/8/2020

8/16/2022

Molecular biology, Medical tests, Barcodes, Biotechnology, Fluid dynamics

Grant

Application Date

5/8/2020

Grant Date

8/16/2022

Title

Related Topics

Molecular biology, Medical tests, Barcodes, Biotechnology, Fluid dynamics

Status

Grant

Latest Binx Health News

17:05 ET POC Molecular Diagnostics Market to grow by USD 1.83 Bn; Abbott Laboratories, Becton Dickinson and Co., binx Health Inc...

Nov 14, 2022

News provided by Share this article Share this article NEW YORK, Nov. 14, 2022 /PRNewswire/ -- The global POC molecular diagnostics market research report provides a detailed analysis of the emerging market trends, regional outlook, competitive landscape, and a comprehensive analysis of different market segments. The report provides a detailed analysis of the market overview, market drivers, opportunities, and potential applications. The POC molecular diagnostics market size is expected to grow by USD 1.83 billion from 2021 to 2026, progressing at a CAGR of 14.67% during the forecast period. View a Free Sample Report Here Key Players Covered in POC Molecular Diagnostics Market Study: Abbott Laboratories: The company offers portable, rapid molecular ID NOW COVID-19 test that allows fast diagnosis with results in 13 minutes or less in a variety of locations such as point-of-care locations. Co-Diagnostics Inc.: The company offers a range of real time PCR kits for accurate simultaneous detection of infectious agents involved in respiratory diseases F. Hoffmann La Roche Ltd.: The company offers point-of-care tests for glucose, urine albumin, and HbA1c as well as total and differential white blood cell count. genedrive plc: The company delivers robust, connected, and easy-to-use point-of-care solutions. QuantuMDx Group Ltd.: The company offers a comprehensive portfolio of SARS-CoV-2 testing solutions. Becton Dickinson and Co. POC Molecular Diagnostics Market Split by Product Based on the product, the market is analyzed across segments such as PCR and microarray and hybridization. PCR products not only identify the genetic material of the infection-causing microorganism but can also identify the gene mutations. Therefore, they are widely used in oncology, prenatal, hematology, and endocrinology applications. POC molecular diagnostic products by the PCR technology are highly sensitive and specific, which facilitates the provision of rapid test results. A significant aspect driving segment growth is the rising desire for personalized and precise treatment. POC Molecular Diagnostics Market Split by Application By application, the market is analyzed across segments such as infectious diseases, oncology, hematology and endocrinology, and others. The market growth in the infectious diseases segment will be significant over the forecast period. The high incidence of infectious diseases has increased the demand for diagnostic tests and new reagents in the market. Infectious diseases are more prevalent in emerging countries when compared with developed nations. Infectious diseases can be tested in laboratories. However, laboratory tests are lengthy, increasing the period to identify the disease. As a result, many companies are manufacturing POC molecular diagnostic products that can detect the molecular levels such as RNA fragments of the virus and provide rapid results. The POC molecular diagnostics market will be affected by the growing focus on technological advances. Apart from this, market trends such as the presence of government funding and the growing number of cancer cases worldwide will have a positive impact on the growth of the market. Imperative Insights on the following aspects: What was the size of the global POC molecular diagnostics industry by value in 2021? What will be the size of the global POC molecular diagnostics industry in 2026? What factors are affecting the strength of competition in the global POC molecular diagnostics industry? How has the industry performed over the last five years? What are the main segments that make up the global POC molecular diagnostics market? Related Reports: The POC hematology diagnostics market share is expected to reach an estimated USD 1.46 billion by 2026 at an accelerating CAGR of 9.06%. The increasing prevalence of blood disorders and infectious diseases is notably driving the POC hematology diagnostics market growth, although factors such as the high cost of hematology diagnostic products may impede the market growth. The helicobacter pylori diagnostics market share is expected to increase by USD 209.59 million from 2020 to 2025, and the market's growth momentum will accelerate at a CAGR of 8.1%. The rising prevalence of the disease is notably driving the helicobacter pylori diagnostics market growth, although factors such as competitive pricing pressure may impede the market growth. POC Molecular Diagnostics Market Scope Report Coverage Companies profiled Abbott Laboratories, Becton Dickinson and Co., binx Health Inc., Co-Diagnostics Inc., Danaher Corp., F. Hoffmann La Roche Ltd., genedrive plc, Lucira Health Inc., Molbio Diagnostics Pvt. Ltd., OraSure Technologies Inc., QIAGEN NV, QuantuMDx Group Ltd., Randox Laboratories Ltd., Robert Bosch GmbH, Siemens AG, Sysmex Corp., Talis Biomedical Corp., Thermo Fisher Scientific Inc., bioMerieux SA, and Quidel Corp. Market Dynamics Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and future consumer dynamics, and market condition analysis for the forecast period. Customization purview If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. Table of Content: Exhibit 28: Data Table on Comparison by Product 5.3 PCR - Market size and forecast 2021-2026  Exhibit 29: Chart on PCR - Market size and forecast 2021-2026 ($ million) Exhibit 30: Data Table on PCR - Market size and forecast 2021-2026 ($ million) Exhibit 31: Chart on PCR - Year-over-year growth 2021-2026 (%) Exhibit 32: Data Table on PCR - Year-over-year growth 2021-2026 (%) 5.4 Microarray and hybridization - Market size and forecast 2021-2026  Exhibit 33: Chart on Microarray and hybridization - Market size and forecast 2021-2026 ($ million) Exhibit 34: Data Table on Microarray and hybridization - Market size and forecast 2021-2026 ($ million) Exhibit 35: Chart on Microarray and hybridization - Year-over-year growth 2021-2026 (%) Exhibit 36: Data Table on Microarray and hybridization - Year-over-year growth 2021-2026 (%) 5.5 Market opportunity by Product  Exhibit 37: Market opportunity by Product ($ million) 6 Market Segmentation by Application 6.1 Market segments Exhibit 41: Data Table on Comparison by Application 6.3 Infectious diseases - Market size and forecast 2021-2026  Exhibit 42: Chart on Infectious diseases - Market size and forecast 2021-2026 ($ million) Exhibit 43: Data Table on Infectious diseases - Market size and forecast 2021-2026 ($ million) Exhibit 44: Chart on Infectious diseases - Year-over-year growth 2021-2026 (%) Exhibit 45: Data Table on Infectious diseases - Year-over-year growth 2021-2026 (%) 6.4 Oncology - Market size and forecast 2021-2026  Exhibit 46: Chart on Oncology - Market size and forecast 2021-2026 ($ million) Exhibit 47: Data Table on Oncology - Market size and forecast 2021-2026 ($ million) Exhibit 48: Chart on Oncology - Year-over-year growth 2021-2026 (%) Exhibit 49: Data Table on Oncology - Year-over-year growth 2021-2026 (%) 6.5 Hematology and endocrinology - Market size and forecast 2021-2026  Exhibit 50: Chart on Hematology and endocrinology - Market size and forecast 2021-2026 ($ million) Exhibit 51: Data Table on Hematology and endocrinology - Market size and forecast 2021-2026 ($ million) Exhibit 52: Chart on Hematology and endocrinology - Year-over-year growth 2021-2026 (%) Exhibit 53: Data Table on Hematology and endocrinology - Year-over-year growth 2021-2026 (%) 6.6 Others - Market size and forecast 2021-2026  Exhibit 54: Chart on Others - Market size and forecast 2021-2026 ($ million) Exhibit 55: Data Table on Others - Market size and forecast 2021-2026 ($ million) Exhibit 56: Chart on Others - Year-over-year growth 2021-2026 (%) Exhibit 57: Data Table on Others - Year-over-year growth 2021-2026 (%) 6.7 Market opportunity by Application  Exhibit 58: Market opportunity by Application ($ million) 7 Customer Landscape Exhibit 63: Data Table on Geographic comparison 8.3 North America - Market size and forecast 2021-2026  Exhibit 64: Chart on North America - Market size and forecast 2021-2026 ($ million) Exhibit 65: Data Table on North America - Market size and forecast 2021-2026 ($ million) Exhibit 66: Chart on North America - Year-over-year growth 2021-2026 (%) Exhibit 67: Data Table on North America - Year-over-year growth 2021-2026 (%) 8.4 Europe - Market size and forecast 2021-2026  Exhibit 68: Chart on Europe - Market size and forecast 2021-2026 ($ million) Exhibit 69: Data Table on Europe - Market size and forecast 2021-2026 ($ million) Exhibit 70: Chart on Europe - Year-over-year growth 2021-2026 (%) Exhibit 71: Data Table on Europe - Year-over-year growth 2021-2026 (%) 8.5 Asia - Market size and forecast 2021-2026  Exhibit 72: Chart on Asia - Market size and forecast 2021-2026 ($ million) Exhibit 73: Data Table on Asia - Market size and forecast 2021-2026 ($ million) Exhibit 74: Chart on Asia - Year-over-year growth 2021-2026 (%) Exhibit 75: Data Table on Asia - Year-over-year growth 2021-2026 (%) 8.6 Rest of World (ROW) - Market size and forecast 2021-2026  Exhibit 76: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million) Exhibit 77: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million) Exhibit 78: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%) Exhibit 79: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%) 8.7 US - Market size and forecast 2021-2026  Exhibit 80: Chart on US - Market size and forecast 2021-2026 ($ million) Exhibit 81: Data Table on US - Market size and forecast 2021-2026 ($ million) Exhibit 82: Chart on US - Year-over-year growth 2021-2026 (%) Exhibit 83: Data Table on US - Year-over-year growth 2021-2026 (%) 8.8 Germany - Market size and forecast 2021-2026  Exhibit 84: Chart on Germany - Market size and forecast 2021-2026 ($ million) Exhibit 85: Data Table on Germany - Market size and forecast 2021-2026 ($ million) Exhibit 86: Chart on Germany - Year-over-year growth 2021-2026 (%) Exhibit 87: Data Table on Germany - Year-over-year growth 2021-2026 (%) 8.9 Canada - Market size and forecast 2021-2026  Exhibit 88: Chart on Canada - Market size and forecast 2021-2026 ($ million) Exhibit 89: Data Table on Canada - Market size and forecast 2021-2026 ($ million) Exhibit 90: Chart on Canada - Year-over-year growth 2021-2026 (%) Exhibit 91: Data Table on Canada - Year-over-year growth 2021-2026 (%) 8.10 China - Market size and forecast 2021-2026  Exhibit 92: Chart on China - Market size and forecast 2021-2026 ($ million) Exhibit 93: Data Table on China - Market size and forecast 2021-2026 ($ million) Exhibit 94: Chart on China - Year-over-year growth 2021-2026 (%) Exhibit 95: Data Table on China - Year-over-year growth 2021-2026 (%) 8.11 France - Market size and forecast 2021-2026  Exhibit 96: Chart on France - Market size and forecast 2021-2026 ($ million) Exhibit 97: Data Table on France - Market size and forecast 2021-2026 ($ million) Exhibit 98: Chart on France - Year-over-year growth 2021-2026 (%) Exhibit 99: Data Table on France - Year-over-year growth 2021-2026 (%) 8.12 Market opportunity by geography  Exhibit 100: Market opportunity by geography ($ million) 9 Drivers, Challenges, and Trends 9.1 Market drivers Exhibit 101: Impact of drivers and challenges in 2021 and 2026 9.4 Market trends 10.3 Landscape disruption 10.4 Industry risks About Us Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios. Contact Us:

Binx Health Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Binx Health Rank

Binx Health Frequently Asked Questions (FAQ)

  • When was Binx Health founded?

    Binx Health was founded in 2005.

  • Where is Binx Health's headquarters?

    Binx Health's headquarters is located at 245 First St, Cambridge.

  • What is Binx Health's latest funding round?

    Binx Health's latest funding round is Series E.

  • How much did Binx Health raise?

    Binx Health raised a total of $203.5M.

  • Who are the investors of Binx Health?

    Investors of Binx Health include Johnson & Johnson Innovation, EQT Life Sciences, Alta Life Sciences, OrbiMed Advisors, Hildred Capital Partners and 17 more.

  • Who are Binx Health's competitors?

    Competitors of Binx Health include Visby Medical, Cardea Bio, Baebies, MeMed, Accellix, Inflammatix, Oxford Nanopore Technologies, LumiraDx, Cue Health, Roche Holding and 37 more.

Compare Binx Health to Competitors

Ellume Logo
Ellume

Ellume is a digital diagnostics company that develops and commercializes connected products for healthcare professionals and consumers. The company has developed a new biosensor technology that features unique optoelectronics and biologics.

C
Cardea Bio

Cardea Bio is a mass producer of biocompatible semiconductors, also called the BPU™ (Biosignal Processing Unit). The BPU is a semiconductor capable of translating real-time streams of multiomics signals into digital information. Through the BPU™ platform, Cardea's long-term vision is to democratize access to the biosignals and insights behind the most advanced technology on the planet: nature and biology. Cardea Bio was founded in 2013 and is based in San Diego, California.

D
DiaSorin

DiaSorin is a multinational biotechnology company that produces and markets in vitro diagnostics reagent kits used in immunodiagnostics and molecular diagnostics. It is based in Saluggia, Italy.

S
Sight Diagnostics

Sight Diagnostics provides affordable and accurate diagnostics in a compact platform designed for use in qualified labs in low volume settings. Its proprietary machine-vision based technology provides the capability to perform multiple tests on a single, easy-to-operate platform.

Cepheid Logo
Cepheid

Cepheid is a molecular diagnostics company that develops, manufactures, and markets fully-integrated systems and tests for genetic analysis in the clinical, industrial, and biothreat markets. The company's systems enable rapid, sophisticated genetic testing for organisms and genetic-based diseases by automating otherwise complex manual laboratory procedures. The company's easy-to-use systems integrate a number of complicated and time-intensive steps, including sample preparation, DNA amplification, and detection, which enable the analysis of complex biological samples in its proprietary test cartridges. Through its strong molecular biology capabilities, the company is focusing on those applications where rapid molecular testing is particularly important, such as identifying infectious disease and cancer in the clinical market; food, agricultural, and environmental testing in the industrial market; and identifying bio-terrorism agents in the biothreat market. Cepheid previously traded under the ticker NASDAQ: CPHD.

Baebies Logo
Baebies

Baebies developed a nimble bioassay automation platform to rapidly perform multiplex enzymatic assays and other tests. The company licensed its core technology, digital microfluidics, from Illumina. In addition to a technology license in newborn screening that does not include sequencing, Baebies also received equipment, contracts, and other consideration in exchange for a share of ownership in the new company. The company was founded in 2013 and is based in Durham, North Carolina.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.